StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.78+0.01 (+0.36%)

Close on Nov 17, 2026Market cap $23.19MP/E –Yield –

Evaxion A/S operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Evaxion A/S's operating cash flow for the twelve months ending Jun 30, 2022 was -$23.79M. For fiscal 2025 it was -$6.63M. The highest annual figure on record is -$1.99M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.63M–
FY2024Dec 31, 2024-$12.94M–
FY2023Dec 31, 2023-$17.69M–
FY2022Dec 31, 2022-$25.77M–
FY2021Dec 31, 2021-$21.93M–
FY2020Dec 31, 2020-$12.44M–
FY2019Dec 31, 2019-$7.02M–
FY2018Dec 31, 2018-$1.99M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2022Jun 30, 2022-$5.19M–
Q1 FY2022Mar 31, 2022-$8.19M–
Q4 FY2021Dec 31, 2021-$4.12M–
Q3 FY2021Sep 30, 2021-$6.30M–
Q2 FY2021Jun 30, 2021-$7.49M–
Q1 FY2021Mar 31, 2021-$4.04M–
Q4 FY2020Dec 31, 2020-$4.42M–
Q3 FY2020Sep 30, 2020-$2.77M–
Q2 FY2020Jun 30, 2020-$2.30M–
Q1 FY2020Mar 31, 2020-$2.95M–

More Evaxion A/S figures

See a number that looks wrong?